ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer

NCT00496665 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Vandetanib
DRUG: Cyclophosphamide
DRUG: Methotrexate

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]